JPWO2023140357A1 - - Google Patents

Info

Publication number
JPWO2023140357A1
JPWO2023140357A1 JP2023554283A JP2023554283A JPWO2023140357A1 JP WO2023140357 A1 JPWO2023140357 A1 JP WO2023140357A1 JP 2023554283 A JP2023554283 A JP 2023554283A JP 2023554283 A JP2023554283 A JP 2023554283A JP WO2023140357 A1 JPWO2023140357 A1 JP WO2023140357A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023554283A
Other versions
JP7479744B2 (ja
JPWO2023140357A5 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023140357A1 publication Critical patent/JPWO2023140357A1/ja
Publication of JPWO2023140357A5 publication Critical patent/JPWO2023140357A5/ja
Priority to JP2024065941A priority Critical patent/JP2024096898A/ja
Application granted granted Critical
Publication of JP7479744B2 publication Critical patent/JP7479744B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
JP2023554283A 2022-01-21 2023-01-20 水性液剤 Active JP7479744B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024065941A JP2024096898A (ja) 2022-01-21 2024-04-16 水性液剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022007774 2022-01-21
JP2022007774 2022-01-21
PCT/JP2023/001725 WO2023140357A1 (ja) 2022-01-21 2023-01-20 水性液剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024065941A Division JP2024096898A (ja) 2022-01-21 2024-04-16 水性液剤

Publications (3)

Publication Number Publication Date
JPWO2023140357A1 true JPWO2023140357A1 (ja) 2023-07-27
JPWO2023140357A5 JPWO2023140357A5 (ja) 2023-12-20
JP7479744B2 JP7479744B2 (ja) 2024-05-09

Family

ID=87348335

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023554283A Active JP7479744B2 (ja) 2022-01-21 2023-01-20 水性液剤
JP2024065941A Pending JP2024096898A (ja) 2022-01-21 2024-04-16 水性液剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024065941A Pending JP2024096898A (ja) 2022-01-21 2024-04-16 水性液剤

Country Status (6)

Country Link
US (1) US20240307544A1 (ja)
JP (2) JP7479744B2 (ja)
KR (1) KR20240134913A (ja)
CN (1) CN118613267A (ja)
MX (1) MX2024009025A (ja)
WO (1) WO2023140357A1 (ja)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
WO2005046700A1 (ja) * 2003-11-14 2005-05-26 Senju Pharmaceutical Co., Ltd. アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
JP2006089460A (ja) * 2004-05-27 2006-04-06 Santen Pharmaceut Co Ltd 眼科用粘稠化剤
JP2013528589A (ja) * 2010-05-05 2013-07-11 センジュ ユーエスエー、インコーポレイテッド 眼科用組成物
CN106420811A (zh) * 2016-12-23 2017-02-22 常州润诺生物科技有限公司 一种氨基糖苷类抗生素的口服制剂及其制备方法与应用
CN106474149A (zh) * 2016-12-23 2017-03-08 常州润诺生物科技有限公司 一种复方氨基糖苷类抗生素的口服制剂及其制备方法与应用
JP2021035984A (ja) * 2008-06-12 2021-03-04 フォーサイト・バイオセラピューティクス・インコーポレーテッド ポビドンヨード、眼科用組成物のための新規代替保存剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274172A (zh) 2004-05-27 2011-12-14 参天制药株式会社 滴眼液
EP2567691B1 (en) 2011-09-12 2014-12-24 Meiji Seika Pharma Co., Ltd. Aqueous compositions comprising arbekacin
AU2016298951B2 (en) 2015-07-27 2019-07-04 Catacore, Inc Compositions for the treatment of cataracts

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
WO2005046700A1 (ja) * 2003-11-14 2005-05-26 Senju Pharmaceutical Co., Ltd. アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
JP2006089460A (ja) * 2004-05-27 2006-04-06 Santen Pharmaceut Co Ltd 眼科用粘稠化剤
JP2021035984A (ja) * 2008-06-12 2021-03-04 フォーサイト・バイオセラピューティクス・インコーポレーテッド ポビドンヨード、眼科用組成物のための新規代替保存剤
JP2013528589A (ja) * 2010-05-05 2013-07-11 センジュ ユーエスエー、インコーポレイテッド 眼科用組成物
CN106420811A (zh) * 2016-12-23 2017-02-22 常州润诺生物科技有限公司 一种氨基糖苷类抗生素的口服制剂及其制备方法与应用
CN106474149A (zh) * 2016-12-23 2017-03-08 常州润诺生物科技有限公司 一种复方氨基糖苷类抗生素的口服制剂及其制备方法与应用

Also Published As

Publication number Publication date
US20240307544A1 (en) 2024-09-19
MX2024009025A (es) 2024-08-06
JP7479744B2 (ja) 2024-05-09
CN118613267A (zh) 2024-09-06
JP2024096898A (ja) 2024-07-17
KR20240134913A (ko) 2024-09-10
WO2023140357A1 (ja) 2023-07-27

Similar Documents

Publication Publication Date Title
BR102023014872A2 (ja)
BR102023005164A2 (ja)
JPWO2023140357A1 (ja)
BR202022009269U2 (ja)
BR202022005961U2 (ja)
BR202022001779U2 (ja)
BR202022000931U2 (ja)
BY13149U (ja)
BY13146U (ja)
BY13160U (ja)
BY13159U (ja)
BY13158U (ja)
BY13157U (ja)
CN307051163S (ja)
CN307050924S (ja)
BY13154U (ja)
CN307050175S (ja)
BY13153U (ja)
BY13152U (ja)
CN307049561S (ja)
CN307049467S (ja)
BY13151U (ja)
BY13150U (ja)
BY13170U (ja)
BY13162U (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230905

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230905

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230905

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230905

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240319

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240417

R150 Certificate of patent or registration of utility model

Ref document number: 7479744

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150